FDA and FTC Tell Monsanto to Quit Bellyaching (Part 2)



Here's the headline I put on the blog entry I just posted about the U.S. Food and Drug Administration's and Federal Trade Commission's responses to complaints from Monsanto that U.S. milk producers are "misleading" the citizenry about the Creve Coeur-based chemical company's product Posilac, a.k.a. rBST, a.k.a. recombinant bovine somatotropin, a.k.a. bovine growth hormone:

FDA and FTC Tell Monsanto to Quit Bellyaching

Now here's the headline from the Business page of yesterday's St. Louis Post-Dispatch, atop a story by Rachel Melcer that covers the exact-same topic:

FTC takes websites to task on claims

Back in April, I wrote a pair of posts, one detailing Monsanto's complaints to the FDA and FTC, the other contrasting Melcer's story for the P-D with stories published by other news outlets.

Well, here we go again.

I'm not going to go over all the old ground. Let me just point you to the only other story about the denouement that's appeared so far, written by Associated Press writer Sam Hananel. That story was published in various newspapers around the nation under this headline:

FTC says milk ads on synthetic hormones not misleading

'Nuff said.

-Tom Finkel

Support Local Journalism.
Join the Riverfront Times Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the Riverfront Times Club for as little as $5 a month.